Canadian cannabis company Tilray is shipping CBD to U.S. clinical researchers. CBD, or cannabidiol, is being studied for the treatment of alcohol-use disorder and post-traumatic stress disorder. It is the second time that Tilray has received approval to send CBD to the U.S. for research. (CNBC)
A study showed that Apple devices with specific apps could identify people with dementia. The research, conducted by Apple, Eli Lilly and Evidation Health, found patients with symptoms of dementia typed slower and received fewer text messages on their iPhones. (Reuters)
Medicare will begin to cover immunotherapy treatments for some blood cancers. Centers for Medicare and Medicaid Services Administrator Seema Verma said the move will provide consistent and predictable access nationwide and open up treatment options. (Associated Press)
The Food and Drug Administration warned companies to stop selling flavored tobacco products. The agency sent letters about flavored e-cigarette liquids and hookah to four companies. FDA said the products were introduced after a rule gave the agency authority over tobacco products. (Reuters)
For MM&M’s October issue, we want to hear about agency culture from the people who live it. We’re asking agency employees far and wide to contribute their stories — the good, the bad and the ugly — as part of a presentation we’re calling Agency Confidential. Send contributions to MM&M‘s Larry Dobrow by Wednesday, August 21.